{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:28:41Z","timestamp":1781562521061,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-024-00562-2","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T09:08:08Z","timestamp":1730884088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["RNF19A inhibits bladder cancer progression by regulating ILK ubiquitination and inactivating the AKT\/mTOR signalling pathway"],"prefix":"10.1186","volume":"19","author":[{"given":"Hao","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"issue":"1","key":"562_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"562_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12967-024-04951-z","volume":"22","author":"T Kong","year":"2024","unstructured":"Kong T, et al. Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis. J Transl Med. 2024;22(1):314.","journal-title":"J Transl Med"},{"issue":"2","key":"562_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber I, et al. Epidemiology of bladder Cancer in 2023: a systematic review of risk factors. Eur Urol. 2023;84(2):176\u201390.","journal-title":"Eur Urol"},{"issue":"19","key":"562_CR4","first-page":"1980","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, et al. Bladder Cancer: Rev Jama. 2020;324(19):1980\u201391.","journal-title":"Bladder Cancer: Rev Jama"},{"issue":"2","key":"562_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, et al. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"9685","key":"562_CR6","first-page":"239","volume":"374","author":"DS Kaufman","year":"2009","unstructured":"Kaufman DS, Shipley WU, Feldman AS. Bladder cancer Lancet. 2009;374(9685):239\u201349.","journal-title":"Bladder cancer Lancet"},{"issue":"8","key":"562_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41419-023-06000-x","volume":"14","author":"D Yan","year":"2023","unstructured":"Yan D, et al. The APC\/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer. Cell Death Dis. 2023;14(8):516.","journal-title":"Cell Death Dis"},{"key":"562_CR8","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743.","journal-title":"BMJ"},{"issue":"1","key":"562_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41420-023-01579-8","volume":"9","author":"H Deng","year":"2023","unstructured":"Deng H, et al. RAB14 promotes epithelial-mesenchymal transition in bladder cancer through autophagy\u2013dependent AKT signaling pathway. Cell Death Discov. 2023;9(1):292.","journal-title":"Cell Death Discov"},{"key":"562_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2021.12.021","volume":"143","author":"Y Yang","year":"2022","unstructured":"Yang Y, et al. RNF19a inhibits antiviral immune response to RNA viruses through degradation of TBK1. Mol Immunol. 2022;143:1\u20136.","journal-title":"Mol Immunol"},{"key":"562_CR11","doi-asserted-by":"publisher","first-page":"100912","DOI":"10.1016\/j.drup.2022.100912","volume":"67","author":"N Zhang","year":"2023","unstructured":"Zhang N, et al. CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer. Drug Resist Updat. 2023;67:100912.","journal-title":"Drug Resist Updat"},{"key":"562_CR12","doi-asserted-by":"publisher","first-page":"16410","DOI":"10.1038\/srep16410","volume":"5","author":"H Park","year":"2015","unstructured":"Park H, et al. Mice lacking the PSD-95-interacting E3 ligase, Dorfin\/Rnf19a, display reduced adult neurogenesis, enhanced long-term potentiation, and impaired contextual fear conditioning. Sci Rep. 2015;5:16410.","journal-title":"Sci Rep"},{"issue":"16","key":"562_CR13","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1111\/jcmm.16674","volume":"25","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, et al. Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth. J Cell Mol Med. 2021;25(16):7796\u2013808.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"562_CR14","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1038\/s41467-021-27048-3","volume":"12","author":"Q Zhu","year":"2021","unstructured":"Zhu Q, et al. RNF19A-mediated ubiquitination of BARD1 prevents BRCA1\/BARD1-dependent homologous recombination. Nat Commun. 2021;12(1):6653.","journal-title":"Nat Commun"},{"issue":"1","key":"562_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41420-024-01919-2","volume":"10","author":"Z Shen","year":"2024","unstructured":"Shen Z, et al. FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation. Cell Death Discov. 2024;10(1):151.","journal-title":"Cell Death Discov"},{"issue":"1","key":"562_CR16","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12964-023-01241-x","volume":"21","author":"J Zhou","year":"2023","unstructured":"Zhou J, et al. RNF173 suppresses RAF\/MEK\/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in hepatocellular carcinoma. Cell Commun Signal. 2023;21(1):224.","journal-title":"Cell Commun Signal"},{"key":"562_CR17","doi-asserted-by":"crossref","unstructured":"Monteiro-Reis S et al. Epigenetic mechanisms influencing epithelial to mesenchymal transition in bladder cancer. Int J Mol Sci, 2019. 20(2).","DOI":"10.3390\/ijms20020297"},{"issue":"1","key":"562_CR18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/s41467-017-02073-3","volume":"8","author":"C Wu","year":"2017","unstructured":"Wu C, et al. NLRP11 attenuates toll-like receptor signalling by targeting TRAF6 for degradation via the ubiquitin ligase RNF19A. Nat Commun. 2017;8(1):1977\u2013p.","journal-title":"Nat Commun"},{"issue":"3","key":"562_CR19","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/ijc.26008","volume":"130","author":"Y Matsui","year":"2012","unstructured":"Matsui Y, et al. The importance of integrin-linked kinase in the regulation of bladder cancer invasion. Int J Cancer. 2012;130(3):521\u201331.","journal-title":"Int J Cancer"},{"issue":"6","key":"562_CR20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cellsig.2012.02.013","volume":"24","author":"J Zhu","year":"2012","unstructured":"Zhu J, et al. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Cell Signal. 2012;24(6):1323\u201332.","journal-title":"Cell Signal"},{"key":"562_CR21","doi-asserted-by":"crossref","unstructured":"He W et al. STRA6 promotes thyroid carcinoma progression via activation of the ILK\/AKT\/mTOR Axis in cells and female nude mice. Endocrinology, 2023. 164(3).","DOI":"10.1210\/endocr\/bqac215"},{"issue":"11","key":"562_CR22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20(11):1242\u201353.","journal-title":"Nat Med"},{"issue":"2","key":"562_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, et al. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28(2):591\u2013605.","journal-title":"Cell Death Differ"},{"issue":"5","key":"562_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41580-021-00448-5","volume":"23","author":"DA Cruz Walma","year":"2022","unstructured":"Cruz Walma DA, et al. Ubiquitin ligases: guardians of mammalian development. Nat Rev Mol Cell Biol. 2022;23(5):350\u201367.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"562_CR25","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.7150\/ijbs.69411","volume":"18","author":"S Han","year":"2022","unstructured":"Han S, et al. The role of ubiquitination and deubiquitination in tumor invasion and metastasis. Int J Biol Sci. 2022;18(6):2292\u2013303.","journal-title":"Int J Biol Sci"},{"issue":"3","key":"562_CR26","doi-asserted-by":"publisher","first-page":"e1204","DOI":"10.1002\/ctm2.1204","volume":"13","author":"C Sampson","year":"2023","unstructured":"Sampson C, et al. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy. Clin Transl Med. 2023;13(3):e1204.","journal-title":"Clin Transl Med"},{"issue":"1","key":"562_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41392-020-00421-2","volume":"6","author":"X Zhou","year":"2021","unstructured":"Zhou X, Sun SC. Targeting ubiquitin signaling for cancer immunotherapy. Signal Transduct Target Ther. 2021;6(1):16.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"562_CR28","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41418-020-00648-0","volume":"28","author":"F Dang","year":"2021","unstructured":"Dang F, Nie L, Wei W. Ubiquitin signaling in cell cycle control and tumorigenesis. Cell Death Differ. 2021;28(2):427\u201338.","journal-title":"Cell Death Differ"},{"issue":"1","key":"562_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1158\/0008-5472.CAN-21-2362","volume":"82","author":"W Jing","year":"2022","unstructured":"Jing W, et al. FGFR3 destabilizes PD-L1 via NEDD4 to control T-cell-mediated bladder Cancer Immune Surveillance. Cancer Res. 2022;82(1):114\u201329.","journal-title":"Cancer Res"},{"key":"562_CR30","doi-asserted-by":"publisher","first-page":"1226057","DOI":"10.3389\/fimmu.2023.1226057","volume":"14","author":"M Wang","year":"2023","unstructured":"Wang M, et al. E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies. Front Immunol. 2023;14:1226057.","journal-title":"Front Immunol"},{"issue":"7","key":"562_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/s41388-023-02922-0","volume":"43","author":"J Yu","year":"2024","unstructured":"Yu J, et al. TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC. Oncogene. 2024;43(7):470\u201383.","journal-title":"Oncogene"},{"issue":"3","key":"562_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41419-021-03521-1","volume":"12","author":"H Xu","year":"2021","unstructured":"Xu H, et al. E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability. Cell Death Dis. 2021;12(3):239.","journal-title":"Cell Death Dis"},{"issue":"15","key":"562_CR33","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.7150\/jca.16798","volume":"7","author":"YY Lee","year":"2016","unstructured":"Lee YY, et al. Downregulation of RNF128 predicts progression and poor prognosis in patients with urothelial carcinoma of the upper tract and urinary bladder. J Cancer. 2016;7(15):2187\u201396.","journal-title":"J Cancer"},{"key":"562_CR34","doi-asserted-by":"publisher","first-page":"101938","DOI":"10.1016\/j.mcp.2023.101938","volume":"72","author":"H Deng","year":"2023","unstructured":"Deng H, et al. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2\/STAT3 signaling pathway. Mol Cell Probes. 2023;72:101938.","journal-title":"Mol Cell Probes"},{"key":"562_CR35","doi-asserted-by":"crossref","unstructured":"Tian T, Li X, Zhang J. mTOR signaling in cancer and mTOR inhibitors in solid tumor targeting therapy. Int J Mol Sci. 2019;20(3).","DOI":"10.3390\/ijms20030755"},{"issue":"1","key":"562_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22(1):138.","journal-title":"Mol Cancer"},{"key":"562_CR37","doi-asserted-by":"crossref","unstructured":"Gargalionis AN et al. mTOR signaling components in tumor mechanobiology. Int J Mol Sci. 2022;23(3).","DOI":"10.3390\/ijms23031825"},{"issue":"189","key":"562_CR38","doi-asserted-by":"publisher","first-page":"rs8","DOI":"10.1126\/scisignal.2001699","volume":"4","author":"A Vinayagam","year":"2011","unstructured":"Vinayagam A, et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal. 2011;4(189):rs8.","journal-title":"Sci Signal"},{"issue":"8","key":"562_CR39","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0006-2952(00)00444-5","volume":"60","author":"TN Yoganathan","year":"2000","unstructured":"Yoganathan TN, et al. Integrin-linked kinase (ILK): a hot therapeutic target. Biochem Pharmacol. 2000;60(8):1115\u20139.","journal-title":"Biochem Pharmacol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-024-00562-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-024-00562-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T21:16:36Z","timestamp":1730927796000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-024-00562-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1186\/s13062-024-00562-2","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the Ethics Committee of Renmin Hospital of Wuhan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors of this study agreed with the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}